Among 131 breast cancer patients, we found that miR-183, miR-182 and miR-96 levels were positively correlated with both TNM stage (P = 0.012, 0.018 and 0.020, respectively) and distant metastasis (P = 0.000, 0.001 and 0.033, respectively) (Table 1) but not with tumor size; LNMET (lymph node metastasis); age; menopause; or ER, PR or HER2 status. The gene discussed is ERBB2; the disease is neoplasm.